Risk of sudden unexpected death in epilepsy (SUDEP) with lamotrigine and other sodium channel-modulating antiseizure medications.

Russell Nightscales Sarah N BarnardJuliana LazeZhibin Chen MBiostatGerard TaoClarissa AuvrezShobi SivathambooMark J CookPatrick KwanDaniel FriedmanSamuel Frank BerkovicWendyl D'SouzaPiero Perucca Orrin DevinskyTerence J O'Brien

Published in: Epilepsia open (2023)

This study provides additional evidence that lamotrigine and other NaM-ASMs are unlikely to be associated with an increased long-term risk of SUDEP, up to 16 years post-EMU admission.

Keyphrases

emergency department